1. Harbeck N, Thomssen C. A new look at node-negative breast cancer. Oncologist. 2011;16(Supplement 1):51–60.
2. Cancer du sein: Epidémiologie, Prise en charge, résultats thérapeutiques rt cout. registre de l’institut Salah Azaiez. 2005:18.
3. Habel LA, Shak S, Jacobs MK, Capra A, Alexander C, Pho M, et al. A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Res. 2006;8(3):R25.
4. Maalej M, Hentati D, Messai T, Kochbati L, El May A, Mrad K, et al. Breast cancer in Tunisia in 2004: a comparative clinical and epidemiological study. Bull Cancer. 2008;95(2):E5–9.
5. Group EBCTsC. Systemic treatment for early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomized trials involving 31000 recurrences and 24000 deaths among 75000 women. Lancet. 1999;339:1–15. 71-85